{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:02:52Z","timestamp":1790420572366,"version":"4.1.0"},"reference-count":30,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.3201\/eid2301.160608","type":"journal-article","created":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T12:05:37Z","timestamp":1481717137000},"page":"56-65","source":"Crossref","is-referenced-by-count":25,"title":["Analysis of Anthrax Immune Globulin Intravenous with Antimicrobial Treatment in Injection Drug Users, Scotland, 2009\u20132010"],"prefix":"10.3201","volume":"23","author":[{"given":"Xizhong","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leisha D.","family":"Nolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Donaldson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad P.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Hendricks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Shadomy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Bothma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Judd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Bower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Q.","family":"Eichacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2301.160608-201612141205-R1","unstructured":"Possession, Use, and Transfer of Select Agents and Toxins, 7 CFR Part 331 [cited 2016 Nov 10]. http:\/\/www.ecfr.gov\/cgi-bin\/retrieveECFR?gp=1&SID=b9126e9fba23e3e7933354a1d2630d72&ty=HTML&h=L&n=7y5.1.1.1.9&r=PART"},{"key":"key-10.3201\/eid2301.160608-201612141205-R2","unstructured":"Possession, Use, and Transfer of Select Agents and Toxins, 9 CFR Part 121 [cited 2016 Nov 10]. http:\/\/www.ecfr.gov\/cgi-bin\/retrieveECFR?gp=1&SID=b9126e9fba23e3e7933354a1d2630d72&ty=HTML&h=L&n=9y1.0.1.5.58&r=PART"},{"key":"key-10.3201\/eid2301.160608-201612141205-R3","unstructured":"Select Agents and Toxins, 42 CFR Part 73 [cited 2016 Nov 10]. http:\/\/www.ecfr.gov\/cgi-bin\/retrieveECFR?gp=&SID=8a4be60456973b5ec6bef5dfeaffd49a&r=PART&n=42y1.0.1.6.61"},{"key":"key-10.3201\/eid2301.160608-201612141205-R4","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1056\/NEJMra1409755","article-title":"Clinical management of potential bioterrorism-related conditions.","volume":"372","author":"Adalja","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2301.160608-201612141205-R5","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.","volume":"7","author":"Jernigan","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2301.160608-201612141205-R6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.mam.2009.07.003","article-title":"Cellular and systemic effects of anthrax lethal toxin and edema toxin.","volume":"30","author":"Moayeri","year":"2009","journal-title":"Mol Aspects Med"},{"key":"key-10.3201\/eid2301.160608-201612141205-R7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0014-5793(02)03228-3","article-title":"Effect of Bacillus anthracis lethal toxin on human peripheral blood mononuclear cells.","volume":"527","author":"Popov","year":"2002","journal-title":"FEBS Lett"},{"key":"key-10.3201\/eid2301.160608-201612141205-R8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1164\/rccm.200608-1239CP","article-title":"Lethal and edema toxins in the pathogenesis of Bacillus anthracis septic shock: implications for therapy.","volume":"175","author":"Sherer","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.3201\/eid2301.160608-201612141205-R9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3201\/eid2002.130687","article-title":"Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.","volume":"20","author":"Hendricks","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2301.160608-201612141205-R10","first-page":"1","article-title":"Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.","volume":"59","author":"Wright","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid2301.160608-201612141205-R11","doi-asserted-by":"publisher","first-page":"e106393","DOI":"10.1371\/journal.pone.0106393","article-title":"Combination therapy with antibiotics and anthrax immune globulin intravenous (AIGIV) is potentially more effective than antibiotics alone in rabbit model of inhalational anthrax.","volume":"9","author":"Kammanadiminti","year":"2014","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2301.160608-201612141205-R12","doi-asserted-by":"publisher","first-page":"5684","DOI":"10.1128\/AAC.00458-13","article-title":"Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax.","volume":"57","author":"Mytle","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2301.160608-201612141205-R13","doi-asserted-by":"crossref","first-page":"19076","DOI":"10.2807\/ese.13.51.19076-en","article-title":"Investigations and control measures following a case of inhalation anthrax in East London in a drum maker and drummer, October 2008.","volume":"13","author":"Anaraki","year":"2008","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid2301.160608-201612141205-R14","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1056\/NEJMcpc1003887","article-title":"Case records of the Massachusetts General Hospital. Case 25-2010. A 24-year-old woman with abdominal pain and shock.","volume":"363","author":"Klempner","year":"2010","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2301.160608-201612141205-R15","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3201\/eid2002.130245","article-title":"Lethal factor and anti-protective antigen IgG levels associated with inhalation anthrax, Minnesota, USA.","volume":"20","author":"Sprenkle","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2301.160608-201612141205-R16","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1086\/512372","article-title":"A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor.","volume":"44","author":"Walsh","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2301.160608-201612141205-R17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jflm.2010.09.008","article-title":"Anthrax in a Scottish intravenous drug user.","volume":"17","author":"Beaumont","year":"2010","journal-title":"J Forensic Leg Med"},{"key":"key-10.3201\/eid2301.160608-201612141205-R18","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3201\/eid2009.131481","article-title":"Confirmed Bacillus anthracis infection among persons who inject drugs, Scotland, 2009-2010.","volume":"20","author":"Booth","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2301.160608-201612141205-R19","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(10)60573-9","article-title":"Anthrax infection in drug users.","volume":"375","author":"Booth","year":"2010","journal-title":"Lancet"},{"key":"key-10.3201\/eid2301.160608-201612141205-R20","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.bjps.2010.06.003","article-title":"The surgical management of injectional anthrax.","volume":"64","author":"Jallali","year":"2011","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"key-10.3201\/eid2301.160608-201612141205-R21","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1053\/j.gastro.2011.02.076","article-title":"An unusual case of peritonitis in an intravenous drug user.","volume":"141","author":"Johns","year":"2011","journal-title":"Gastroenterology"},{"key":"key-10.3201\/eid2301.160608-201612141205-R22","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1302\/0301-620X.93B3.25976","article-title":"Subcutaneous anthrax in three intravenous drug users: a new clinical diagnosis.","volume":"93","author":"Knox","year":"2011","journal-title":"J Bone Joint Surg Br"},{"key":"key-10.3201\/eid2301.160608-201612141205-R23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1136\/jcp.2010.082586","article-title":"Injection anthrax causing compartment syndrome and necrotising fasciitis.","volume":"64","author":"Parcell","year":"2011","journal-title":"J Clin Pathol"},{"key":"key-10.3201\/eid2301.160608-201612141205-R24","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3201\/eid1808.111343","article-title":"Molecular epidemiologic investigation of an anthrax outbreak among heroin users, Europe.","volume":"18","author":"Price","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2301.160608-201612141205-R25","unstructured":"Scotland HP. An outbreak of anthrax among drug users in Scotland, December 2009 to December 2010, A report on behalf of the National Anthrax Outbreak Control Team. December 2011 [cited 2016 Apr 4]. http:\/\/wwwdocumentshpsscotnhsuk\/giz\/anthrax-outbreak\/anthrax-outbreak-report-2011-12pdf"},{"key":"key-10.3201\/eid2301.160608-201612141205-R26","unstructured":"Gallegos-Candela M, Boyer AE, Quinn CP, Woolfitt AR, Barr JR. Validation of rapid, sensitive, quantitative MALDI-TOF MS assays for anthrax lethal factor and lethal toxin. Bacillus-ACT 2009: The International\n                      Bacillus anthracis, B cereus\n                      , and\n                      B thuringiensis\n                      conference; 2009 Aug 30\u2013Sep 3; Santa Fe (NM)."},{"key":"key-10.3201\/eid2301.160608-201612141205-R27","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"key-10.3201\/eid2301.160608-201612141205-R28","unstructured":"Health Protection Scotland. Interim clinical guidance for the management of suspected anthrax in drug users [cited 2016 Apr 4]. http:\/\/wwwdocumentshpsscotnhsuk\/giz\/anthrax-outbreak\/clinical-guidance-for-use-of-anthrax-immune-globulin-v12-1-2010-03-19pdf"},{"key":"key-10.3201\/eid2301.160608-201612141205-R29","doi-asserted-by":"publisher","first-page":"e30201","DOI":"10.1371\/journal.pone.0030201","article-title":"Debridement increases survival in a mouse model of subcutaneous anthrax.","volume":"7","author":"Weiner","year":"2012","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2301.160608-201612141205-R30","doi-asserted-by":"publisher","first-page":"376","DOI":"10.7861\/clinmedicine.14-4-376","article-title":"Intensive care medicine is 60 years old: the history and future of the intensive care unit.","volume":"14","author":"Kelly","year":"2014","journal-title":"Clin Med (Lond)"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/23\/1\/16-0608_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T18:28:33Z","timestamp":1732904913000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/23\/1\/16-0608_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2301.160608","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}